Novartis Aktie
98,72
EUR
-0,68
EUR
-0,68
%
92,03
CHF
-0,26
CHF
-0,28
%
Werbung
Novartis Aktie Analyse
11.12.12 | Novartis halten | Norddeutsche Landesbank (Nord/LB) | |
10.12.12 | Novartis neutral | J.P. Morgan Cazenove | |
06.11.12 | Novartis neutral | J.P. Morgan Cazenove | |
05.11.12 | Novartis neutral | Citigroup Corp. | |
29.10.12 | Novartis halten | Independent Research GmbH | |
16.10.12 | Novartis neutral | Citigroup Corp. | |
08.10.12 | Novartis halten | Independent Research GmbH | |
12.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
Werbung
|
|||
07.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
06.09.12 | Novartis neutral | Exane-BNP Paribas SA | |
04.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
31.08.12 | Novartis neutral | J.P. Morgan Cazenove | |
29.08.12 | Novartis neutral | Citigroup Corp. | |
24.08.12 | Novartis neutral | Exane-BNP Paribas SA | |
20.08.12 | Novartis neutral | Goldman Sachs Group Inc. | |
30.07.12 | Novartis hold | Vontobel Research | |
23.07.12 | Novartis hold | Vontobel Research | |
20.07.12 | Novartis hold | Vontobel Research | |
20.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
19.07.12 | Novartis halten | Independent Research GmbH | |
19.07.12 | Novartis hold | Vontobel Research | |
19.07.12 | Novartis hold | Vontobel Research | |
18.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
12.07.12 | Novartis neutral | J.P. Morgan Cazenove | |
12.07.12 | Novartis hold | Vontobel Research | |
12.07.12 | Novartis neutral | Citigroup Corp. | |
11.07.12 | Novartis neutral | J.P. Morgan Cazenove | |
25.06.12 | Novartis neutral | UBS AG | |
19.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
19.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
11.06.12 | Novartis hold | Vontobel Research | |
08.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
05.06.12 | Novartis hold | Vontobel Research | |
04.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
04.06.12 | Novartis neutral | Citigroup Corp. | |
04.06.12 | Novartis hold | Vontobel Research | |
29.05.12 | Novartis neutral | J.P. Morgan Cazenove | |
23.05.12 | Novartis hold | Vontobel Research | |
18.05.12 | Novartis hold | Vontobel Research | |
04.05.12 | Novartis neutral | Banc of America Securities-Merrill Lynch | |
03.05.12 | Novartis neutral | J.P. Morgan Cazenove | |
03.05.12 | Novartis hold | Vontobel Research | |
30.04.12 | Novartis hold | Vontobel Research | |
25.04.12 | Novartis neutral | Exane-BNP Paribas SA | |
25.04.12 | Novartis hold | Vontobel Research | |
24.04.12 | Novartis halten | Independent Research GmbH | |
24.04.12 | Novartis hold | Vontobel Research | |
10.04.12 | Novartis neutral | J.P. Morgan Cazenove | |
03.04.12 | Novartis neutral | J.P. Morgan Cazenove | |
16.03.12 | Novartis neutral | Exane-BNP Paribas SA |
Werbung
Werbung